Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Percutaneous Transluminal Angioplasty Balloons Market: By Product Type, By Application, By End Users, By Route of Administration, and Region Forecast 2020-2031
Percutaneous Transluminal Angioplasty (PTA) Balloons Market size was valued at US$ 2.9 billion in 2024 and is expected to reach US$ 5.0 million by 2031, growing at a significant CAGR of 8.3% from 2025-2031. Percutaneous transluminal angioplasty (PTA) is a process carried to treat the peripheral artery disease (PAD) by open up the arteries that are narrowed by plaque. Percutaneous transluminal angioplasty (PTA) is a procedure in which a small flexible catheter with a diameter of only a few millimetres is introduced into an artery and guided to a desired site where the blood vessel has narrowed due to cardiovascular disease. A tiny balloon is inflated at the end of the catheter when it reaches the target place, squeezing the blocking component responsible for the restricted artery against the blood vessel wall and restoring normal blood flow. When the balloon is inflated, the blood vessel opening widens, allowing more blood to flow to the heart. During the procedure, a stent is frequently used to maintain the artery open after the balloon is deflated and removed.
Superior technological advancements such as progressive flexibility due to innovations in hydrophilic design, superior hydrophilic coatings, improved performance under high pressure due to added pushability, and robust design reducing friction are expected to drive the global percutaneous transluminal angioplasty balloons market growth during the forecast period. Rising reimbursement coverage for the treatment of cardiac diseases, especially among end-users in developing countries (which have a relatively higher patient population), are some of the factors likely to drive the growth of the global percutaneous transluminal angioplasty balloons market between 2017 and 2025. However, the risk of patient discomfort during balloon inflation and the possibility of restenosis are two factors that are anticipated to limit the worldwide Percutaneous Transluminal Angioplasty (PTA) Balloons Market growth over the forecast period.
Study Period
2025-2031Base Year
2024CAGR
8.3%Largest Market
North-AmericaFastest Growing Market
Europe
Increase in the prevalence of peripheral or coronary artery diseases, development in imaging technologies, recent launch of several percutaneous transluminal angioplasty balloons, and rise in R&D for the manufacturing of advanced technology balloons such as drug-eluting balloons are anticipated to fuel the percutanleous transluminal angioplasty balloons market over the forecast period. However, stringent guidelines for product approval, high cost of PTA balloons, and lack of awareness about advanced PTA balloons in underdeveloped countries may restrain the growth of percutaneous transluminal angioplasty balloons market.
Report Benchmarks |
Details |
Report Study Period |
2025-2031 |
Market Size in 2024 |
US$ 2.9 billion |
Market Size in 2031 |
US$ 5.0 million |
Market CAGR |
8.3% |
By Product Type |
|
By Application |
|
By End User |
|
By Route of Administration |
|
By Region |
|
Download Free Sample Report
Percutaneous transluminal angioplasty (PTA) balloons market size was valued at US$ 2.9 billion in 2024 and is expected to reach US$ 5.0 million by 2031, growing at a significant CAGR of 8.3%.
The Percutaneous Transluminal Angioplasty (PTA) Balloons Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Europe is the fastest-growing for Percutaneous Transluminal Angioplasty (PTA) Balloons Market
1.Executive Summary |
2.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Introduction |
2.1.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market - Taxonomy |
2.2.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market - Definitions |
2.2.1.Product Type |
2.2.2.Application |
2.2.3.End User |
2.2.4.Route of Administration |
2.2.5.Region |
3.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Analysis, 2020-2024 and Forecast 2025-2031 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Product Type, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
5.1. Drug-Eluting Balloons |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Normal Balloons |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Scoring Balloons |
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Cutting Balloons |
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Application, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
6.1. Peripheral Artery Disease |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Coronary Artery Disease |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By End User, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Cardiology Clinics |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Ambulatory Surgical Centers |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Route of Administration, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
8.1. Injection |
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Nasal Spray |
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Region, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
10.1. Product Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Drug-Eluting Balloons |
10.1.2.Normal Balloons |
10.1.3.Scoring Balloons |
10.1.4.Cutting Balloons |
10.2. Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Peripheral Artery Disease |
10.2.2.Coronary Artery Disease |
10.3. End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Cardiology Clinics |
10.3.3.Ambulatory Surgical Centers |
10.4. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Injection |
10.4.2.Nasal Spray |
10.5. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Drug-Eluting Balloons |
11.1.2.Normal Balloons |
11.1.3.Scoring Balloons |
11.1.4.Cutting Balloons |
11.2. Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Peripheral Artery Disease |
11.2.2.Coronary Artery Disease |
11.3. End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Cardiology Clinics |
11.3.3.Ambulatory Surgical Centers |
11.4. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Injection |
11.4.2.Nasal Spray |
11.5. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12.Asia Pacific (APAC) Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Drug-Eluting Balloons |
12.1.2.Normal Balloons |
12.1.3.Scoring Balloons |
12.1.4.Cutting Balloons |
12.2. Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Peripheral Artery Disease |
12.2.2.Coronary Artery Disease |
12.3. End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Cardiology Clinics |
12.3.3.Ambulatory Surgical Centers |
12.4. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Injection |
12.4.2.Nasal Spray |
12.5. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Drug-Eluting Balloons |
13.1.2.Normal Balloons |
13.1.3.Scoring Balloons |
13.1.4.Cutting Balloons |
13.2. Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Peripheral Artery Disease |
13.2.2.Coronary Artery Disease |
13.3. End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Cardiology Clinics |
13.3.3.Ambulatory Surgical Centers |
13.4. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Injection |
13.4.2.Nasal Spray |
13.5. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Drug-Eluting Balloons |
14.1.2.Normal Balloons |
14.1.3.Scoring Balloons |
14.1.4.Cutting Balloons |
14.2. Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Peripheral Artery Disease |
14.2.2.Coronary Artery Disease |
14.3. End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Hospitals |
14.3.2.Cardiology Clinics |
14.3.3.Ambulatory Surgical Centers |
14.4. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Injection |
14.4.2.Nasal Spray |
14.5. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.R. Bard, Inc. (U.S.) |
15.2.2.Cook Medical, Inc. (U.S.) |
15.2.3.Abbott, Inc. (U.S.) |
15.2.4.Cardinal Health, Inc. (U.S.) |
15.2.5.Boston Scientific Corporation (U.S.) |
15.2.6.Spectranetics Corporation (Philips Holding USA Inc.) (U.S.) |
15.2.7.Medtronic Plc (Ireland) |
15.2.8.SurModics Inc. (U.S.) |
15.2.9.ENDOCOR GmbH (Germany) |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players